Trial Profile
A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow during Primary PCI for the Acute Myocardial InfartiON ERUPTION
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2017
Price :
$35
*
At a glance
- Drugs Urokinase (Primary) ; Tirofiban
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ERUPTION
- 07 Mar 2017 New trial record